نتایج جستجو برای: simvastatin

تعداد نتایج: 13002  

Journal: :Hypertension 2004
Kwang Kon Koh Ji Won Son Jeong Yeal Ahn Dae Sung Kim Dong Kyu Jin Hyung Sik Kim Seung Hwan Han Yiel-Hea Seo Wook-Jin Chung Woong Chol Kang Eak Kyun Shin

Mechanisms underlying biological effects of statin and angiotensin-converting enzyme inhibitor therapies differ. Thus, we studied vascular responses to combination therapy in hypercholesterolemic patients. A randomized, double-blind, placebo-controlled, crossover trial was conducted with 50 hypercholesterolemic patients with simvastatin and either placebo or ramipril (study I) and in 45 hyperch...

Journal: :The Journal of pharmacology and experimental therapeutics 2011
Samith T Kochuparambil Belal Al-Husein Anna Goc Sahar Soliman Payaningal R Somanath

Prostate cancer is the second-leading cause of cancer-associated death among men in the United States. There has been renewed interest in the potential therapeutic benefits of statins for cancer. Simvastatin, a widely used generic drug for preventing cardiovascular events, is well known for its effects on cellular proliferation and inflammation, two key processes that also determine the rate of...

2012
William Berger Dale Mohar Gordon Raphael Craig LaForce Holly Huang Shailesh Desai Frederick Bode John Karafilidis

153 Effect of Simvastatin on Transforming Growth Factor BETA-1Induced Myofibroblast Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts Il-Ho Park, MD, and Heung-man Lee, MD, PhD. Department of otorhinolaryngology-head and neck surgery, Korea university college of medicine, Seoul, South Korea. Background: Statins are the most commonly prescribed drugs for the treatment of...

2016
Sanne Tofte Rasmussen Jon Trærup Andersen Torben Kjær Nielsen Vanja Cejvanovic Kasper Meidahl Petersen Trine Henriksen Allan Weimann Jens Lykkesfeldt Henrik Enghusen Poulsen

Simvastatin reduces the blood concentration of cholesterol by inhibiting hydroxymethylglutaryl-coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis, and thereby reduces the risk of cardiovascular disease. In addition, simvastatin treatment leads to a reduction in fluxes in mitochondrial respiratory complexes I and II and might thereby reduce the formation of reactive oxygen s...

Journal: :Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2017
E K Kim J H Cho A R Jeong E J Kim D K Park K A Kwon J W Chung K O Kim J H Kim Y J Kim

Small bowel injury can occur as the result of a multifaceted process that includes increased acid secretion, generation of reactive oxygen species, and cyclooxygenase inhibition. However, no effective medication for small bowel ulceration is available. Simvastatin is an important lipid-lowering agent with anti-inflammatory activity. We aimed to validate the effects of simvastatin in vitro and i...

2012
Kwonil Jung Qiuhong Wang Yunjeong Kim Kelly Scheuer Zhenwen Zhang Quan Shen Kyeong-Ok Chang Linda J. Saif

The lack of an animal model for human norovirus (HuNoV) has hindered the development of therapeutic strategies. This study demonstrated that a commonly used cholesterol-lowering statin medication, simvastatin, which increases HuNoV replication in an in vitro replicon system, also enhances HuNoV infectivity in the gnotobiotic (Gn) pig model. In contrast, oral treatment with interferon (IFN)-α re...

2014
Joseph P. Kitzmiller Jasmine A. Luzum Damiano Baldassarre Ronald M. Krauss Marisa W. Medina

OBJECTIVE Simvastatin is primarily metabolized by CYP3A4. A combined CYP3A4/5 genotype classification, combining the decrease-of-function CYP3A4*22 and the loss-of-function CYP3A5*3, has recently been reported. We aim to determine whether CYP3A4*22 and CYP3A5*3 alleles are associated with increased plasma concentrations of simvastatin lactone (SV) and simvastatin acid (SVA). This is the first r...

Journal: :American journal of physiology. Heart and circulatory physiology 2005
Tsung-Ming Lee Mei-Shu Lin Tsai-Fwu Chou Nen-Chung Chang

Epidemiological studies showed that hypercholesterolemia is associated with higher left ventricular mass. Endothelin signaling is activated in hyperlipidemic animals and may contribute to progressive ventricular hypertrophy. Simvastatin has been shown to inhibit endothelin-1. However, the behavior of simvastatin on ventricular hypertrophy in hyperlipidemic animals is not well understood. In thi...

2010
Yong-Qing Chen Lian-You Zhao Wei-Ze Zhang Ming-Xu Zhang Ling Ma

Objective To study the effects of simvastatin on the hypertrophy of cultured rat cardiac myocytes induced by serum and the role of phosphatase and tensin homolog deleted on chromosome ten (PTEN) in the signal pathway. Methods Cultured neonatal SpragueDawley (SD) rat cardiac myocytes were treated with 15% fetal bovine serum, or without serum, or different consentrations of simvastatin. Image ana...

Journal: :iranian journal of pharmaceutical research 0
mahsima khoshneviszadeh medicinal & natural products chemistry research center, shiraz university of medical sciences, shiraz, iran soheil ashkani-esfahani student research committee, shiraz university of medical sciences, shiraz, iran mohammad reza namazi department of dermatology, shiraz university of medical sciences, shiraz, iran ali noorafshan histomorphometry & stereology research centre, shiraz university of medical sciences, shiraz, iran bita geramizadeh department of pathology, shiraz university of medical sciences, shiraz, iran ramin miri medicinal & natural products chemistry research center, shiraz university of medical sciences, shiraz, iran

wounds and wound healing have always been one of the most important subjects that experimental researches were dedicated to. simvastatin has been used for long as a common lipid lowering agent which was reported to have some pleiotropic effects such as antioxidation, anti-inflammation and immunomodulation. in this study we aimed to determine the effect of simvastatin on wound healing process in...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید